Bahrain cabinet approves VAT amendment    Exhibition on the field, digital expansions at Grand Mosque opened    The Saudi diversity is a great national wealth    Mobile clinics open for COVID-19 vaccination in Al-Qassim    Saudi Arabia conducts over 28 million COVID-19 tests    SIDF wins IDC award for excellence in digital innovation    Indian farmers intensify protest against reforms    PIF acquires 25% stake in Emaar Economic City    Heavy rains as Cyclone Gulab makes landfall in southern India    Japan's Princess Mako to give up one-off payment in controversial marriage    Social Democrats narrowly beat Merkel's center-right Union bloc in German elections    Australia PM may skip Glasgow climate summit    UK suspends competition law to get petrol to forecourts    Golf Saudi launches Dirab Golf & Country Club on 91st Saudi National Day    Winter at Tantora returns to AlUla along with 3 momentous new events in December    29 artists from 10 countries showcase creativity to audience of ISFHE in early October    Saudi music legend Mohamed Abdo to perform at Expo 2020's opening ceremony    SAMF achieves world record for largest brick built F1 car    Saudi Automobile and Motorcycle Federation unveils largest Formula 1 car model    Saudis, expats mourn death of prominent Filipino preacher in Riyadh    Al Burj, Chinar, CSG, Kashmir Stags, ARM, Pak Zalmi record big wins in Kanoo League    Bollywood actor Sidharth Shukla dies at 40    Custodian of the Two Holy Mosques Directs KSrelief to Urgently Provide Malaysia with Medical, Preventive Equipment and Supplies to Address COVID-19 Pandemic    Custodian of the Two Holy Mosques Congratulates President of Maldives on Independence Day    Weather Forecast for Sunday    RSNF Commander Patronizes Ceremonial Launching of His Majesty's Ship "Jazan"    OIC Condemns Houthi Attempts to Target Civilians in Saudi Arabia    Philippines evacuates thousands as monsoon rains flood cities, provinces    Heavy rain in India triggers floods, landslides; at least 125 dead    U.S. Records 64,321 New Infections of Coronavirus    Without Fans, Tokyo Olympics Kicked Off    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Dr. Mohammed Sulaiman Al-Jasser, Saudi Arabia's Pick to Chair IsDB Group for the next five years, unanimously approved by BoG Committee of Procedures    Saudi Press: Fitch affirms Saudi Credit Rating at "A" with a revised outlook to stable from negative    Handled Cargo at Saudi Ports Increases during June 2021    SDAIA, DARP & STC Launch Pilgrim's Smart Bracelet (NUSK)    Tabuk sculptor spends 8 years in carving entire Holy Qur'an on 30 marble slabs    2 Goals by Diaz Gives Colombia 3rd Place at Copa America    Legendary actor Dilip Kumar, 98, passes away, and with him an era    Saudi Cinema Night at Arab World Institute in Paris Kicks Off    KSU Leads Joint International Scientific Project for Early Detection of Breast Cancer    Saudi Arabia to Participate in Cannes Film Festival 2021    Arab Cup U-17 Championship Draw Saudi Arabia, Morocco, Palestine, Kuwait, in the 1st Group    AWI Hosts Saudi Cinema Nights in Paris    Brazil Beats Chile at Copa America Despite 2nd-Half Red Card    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Benefits of AstraZeneca vaccine outweigh risks, asserts SFDA No confirmed cases of platelet deficiency, thrombosis recorded: MoH
Published in The Saudi Gazette on 19 - 04 - 2021

RIYADH — Dr. Abdullah Al-Asiri, assistant deputy minister of health for preventive health, reassured the Saudi society that no confirmed cases of platelet deficiency and blood clotting associated presumably with COVID-19 vaccines have so far been registered in the Kingdom.
Dr. Al-Asiri, who is also a consultant in infectious diseases, emphasized that not every stroke after receiving vaccine shots is due to vaccination. "Thanks to God, vaccines are saving lives every day."
In a statement on his Twitter account, the deputy minister expressed surprise over the rumors regarding some side effects of the vaccine, exclaiming "how a wrong conclusion drawn from a generalization has become the most circulated news!" Pointing to the benefits of vaccination, Dr. Al-Asiri observed: "Members of my family, including parents, siblings, and children, have received the first dose of AstraZeneca and are looking forward to having the second dose soon."
Meanwhile, the Saudi Food and Drug Authority (SFDA) has assured that the benefits of the Oxford-AstraZeneca coronavirus vaccine outweigh the potential risks according to the approved medical claims. The authority highlighted the major benefits of taking the vaccine, pointing out that the reported side effects were much lower as compared to its great benefits.
The assurances of SFDA came in light of the reported 15 thrombosis and low platelet cases as side effects of the vaccine. According to the number of local reports received by the authority, the rate of incidents of these symptoms in the Kingdom is one infection for every 200,000 people.
It has also been found that there are a number of possibilities for the mechanism of these symptoms occurring with the use of the vaccine, and one of the likely possibilities is that the vaccination will lead to the emergence of an unexpected reaction in the immune system causing tremendous activation in the platelets, which leads to a decrease in their number and the occurrence of clots. Also, there is a possibility of similar side effects with some vaccines used in the expanded vaccination programs.
However, the rate of occurrence of these side effects related to administering of other vaccines, in general, ranged between one case per 1,000,000 to one case per 125,000 people, according to the available evidence.
Okaz/Saudi Gazette has also learned that the SFDA has directed the health authorities, through a circular, to apply precautionary measures, in order to reduce the potential risks due to administering the vaccine in general, with spelling out the following procedures: Inform the vaccine recipient of the need to consult the treating doctor or go to the nearest health center when any of the following symptoms appear and continue for more than three days after receiving the vaccine — dizziness, severe and persistent headache, nausea or vomiting, visual impairment, shortness of breath, severe pain in the chest or abdomen or cold in the extremities, swelling of the legs, small blood spots under the skin in places other than the injection site.
The authority advised to postpone the use of the vaccine for those people who suffer from unstable diseases that required a fundamental change in the treatment plan or required hospitalization during the six weeks prior to the date of administration of the vaccine.
The precautionary measures included consulting the physician and making sure that the potential benefits from receiving the vaccine outweigh the risks for the following groups: people with multiple chronic diseases; people who have risk factors for developing blood clotting disorders such as those who have autoimmune diseases, or women who take birth control pills, or people with a previous history of blood clotting.
The precautionary measures to reduce the risks of the vaccine should also include providing a guide for diagnosing and treating blood clotting disorders after receiving the vaccine, and stressing the need to inform the authority about all cases of side effects associated with COVID-19.
The SFDA follows up the safety file of the vaccines and reviews the reports received by the authority from all its scientific and technical teams and submitting them to the relevant committees such as the causation assessment committee, the advisory committee for blood diseases and infectious diseases, and the advisory committee for pharmacovigilance.
The authority also reviews the data of measuring symptoms and side effects associated with the vaccine available in the World Health Organization database and monitored from various countries of the world, in addition to the evaluation of the available evidence.


Clic here to read the story from its source.